Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Bayer research into metabotropic glutamate receptor ligands proves fruitful

Aug. 17, 1999

Neuronal calcium channel-modulating compounds from Lilly useful in treating CNS disorders

Aug. 17, 1999

Melatonin antagonist S-22153 blocks phase-advancing effects of melatonin in vivo in mice

Aug. 17, 1999

Centaur researches novel treatments for Alzheimer's disease

Aug. 16, 1999

5-HT1A receptor agonist LB-50016, a novel putative anxiolytic and antidepressant

Aug. 16, 1999

ADIR researching new treatments for sleep disorders

Aug. 13, 1999

Novel MAO-A inhibitors from Sanofi-Synthelabo are claimed for various CNS disorders

Aug. 13, 1999

Budipine is a novel and safe antiparkinsonian agent

Aug. 13, 1999

Wealth of preclinical data supports anxiolytic potential of 5-HT1A inverse agonist SL-88.0338

Aug. 13, 1999

VIP analogues: a new neuroprotective approach to antiparkinsonian drug therapy

Aug. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...